Orexigen Therapeutics Inc OREX shares advanced 19.43% to $3.38 at 9:49 am. OREX is scheduled to announce a regulatory update on Contrave NDA on June 3, 2011 before the opening bell.
Read more here.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
